Development and validation of a deep learning model integrating 18F-FDG PET/CT radiomics and clinical features to predict major pathological response in non-small cell lung cancer patients receiving chemoimmunotherapy
Background Pathological complete response (pCR) and major pathological response (MPR) are early measures of treatment efficacy with prognostic relevance in patients with non-small cell lung cancer (NSCLC) receiving neoadjuvant chemoimmunotherapy. Individual biomarkers such as programmed cell death-ligand 1 (PD-L1) and...